Their FDA-approved indications have included treatment of MDD (in adult 70 and pediatric patients), adjunctive therapy to existing MDD treatment, and treatment-resistant 71 depression.
Depression Medicines | FDA - U.S. Food and Drug Administration
Use the following information to help you talk to your healthcare provider about medicines called antidepressants that can help treat depression. The medicine charts list FDA-approved products...
DDT COA #000008: Symptoms of Major Depressive Disorder Scale - FDA
experienced a major depressive episode within the last 6 months; a HAM-D score > 18 meets the DSM-IV or DSM-V criteria for MDD; COA Type PRO. Requestor(s)
FDA clears first digital treatment for depression, but experts ... - CNN
Apr 2, 2024 · The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.
FDA Approves Spravato Nasal Spray for Major Depressive Disorder
Jan 23, 2025 · The U.S. Food and Drug Administration (FDA) this week approved Johnson & Johnson’s Spravato (a ketamine-derived) nasal spray to treat major depressive disorder (MDD). It marks the first standalone MDD treatment for adults who haven’t responded to at least two oral antidepressants.
FDA Approves First, Only NMDA Receptor Antagonist for Major Depressive ...
Aug 19, 2022 · Auvelity is the first and only rapid-acting oral medication approved for major depressive disorder with labeling of statistically significant antidepressant efficacy compared to placebo starting at 1 week.
Newly FDA-Cleared TMS for Major Depressive Disorder, …
Nov 12, 2024 · The FDA has granted clearance to the Horizon Inspire transcranial magnetic stimulation system to treat major depressive disorder, obsessive-compulsive disorder, and anxious depression.
Major Depressive Disorder: Developing Drugs for Treatment; …
Jun 21, 2018 · FDA is announcing the availability of a draft guidance for industry entitled “Major Depressive Disorder: Developing Drugs for Treatment.” The purpose of this draft guidance is to assist sponsors in the clinical development of drugs for the monotherapeutic, combination, and adjunctive treatment of MDD.
Major Depressive Disorder: Developing Drugs for Treatment
Nov 30, 2024 · Issued by: Food and Drug Administration (FDA) HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible.
List of 57 Major Depressive Disorder Medications Compared - Drugs.com
Compare risks and benefits of common medications used for Major Depressive Disorder. Find the most popular drugs, view ratings and user reviews.